Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial

Margaret V. Ragni, Scott D. Rothenberger, Robert Feldman, Danielle Nance, Andrew D. Leavitt, Lynn Malec, Roshni Kulkarni, Robert F. Sidonio, Eric H. Kraut, Joseph L. Lasky, Rajiv K. Pruthi, Dana E. Angelini, Claire S. Philipp, Nina Hwang, Allison P. Wheeler, Craig D. Seaman, Nicoletta Machin, Frederico Xavier, Michael Meyer, Daniel B. Bellissimo, Gregory Humphreys, Kenneth J. Smith, Elizabeth P. Merricks, Timothy C. Nichols, Dana Ivanco, Deborah Vehec, Glory Koerbel, Andrew D. Althouse